The LeukoStrat CDx FLT3 Mutation Assay can now be used in Japan as the CDx for quizartinib for the treatment of FLT3-ITD positive relapsed or refractory AML.
New Japanese guidelines would allow for gene editing of human embryos for research purposes, according to Nature News.
Japan's science ministry wants a budget increase of about 20 percent, Science reports.
Japanese broadcaster NHK reports that a Japanese government panel has decided not to regulate some types of gene editing.
The firm's ROS1 gene fusion kit was approved as a companion diagnostic for Pfizer's Xalkori.
The Japan Times says regulations are needed to oversee human genome-editing research.
Japan needs to catch up on its gene-editing research efforts, the Japan News writes.
Japan is creating its first biosafety level-4 lab in response to concerns about the Ebola outbreak, Nature News reports.
The center, based in Yokohama, Japan, will likely purchase at least one single-molecule sequencer in order to avoid PCR-induced bias in Cap Analysis of Gene Expression, a method its researchers developed.
Three genetic testing companies form a coalition to influence how Congress considers genetic privacy, The Hill reports.
University of California, San Diego researchers investigate how skin care products influence the skin microbiome, Scientific American reports.
The Wall Street Journal examines billing codes used by uBiome.
In PNAS this week: links between lung adenocarcinoma and lncRNA, algorithm to impute and cluster Hi-C interaction profiles from single cells, and more.